Abstract
Background
Uterine epithelioid angiosarcoma is extremely rare. Evidence-based advice regarding optimal management is lacking.
Method
We report the 22nd case in the world literature and review all the cases reported in English since 1900. An attempt is made to generate information that may help in the management based on the available literature.
Results
A 54-year-old woman was found to have an enlarged uterus on routine clinical examination. Although, she had no other symptoms, an endometrial biopsy was performed, which indicated a high-grade sarcoma. She was taken for a total abdominal hysterectomy and bilateral salpingo-oophorectomy and final histology returned a diagnosis of epithelioid angiosarcoma of the uterus. Two months later, she had tumor recurrence and was started on gemcitabine and taxotere later changed to albumin-bound paclitaxel (ABI-007, Abraxane™) and bevacizumab. She was still alive with no evidence of disease at the time of this report, 12 months after diagnosis. Literature review suggests that surgical resection followed by chemotherapy is a reasonable management approach.
Conclusion
Uterine epithelioid angiosarcoma is an uncommon but very aggressive disease. Surgical resection followed by sequential chemotherapy is a reasonable management approach, and modern chemotherapy and anti-angiogenic agents may have merit.
Similar content being viewed by others
References
Abrahamson TG, Stone MS, Piette WW (2001) Cutaneous angiosarcoma. Adv Dermatol 17:279–299
Rao J, Dekoven JG, Beatty JD, Jones G (2003) Cutaneous angiosarcoma as a delayed complication of radiation therapy for carcinoma of the breast. J Am Acad Dermatol 49(3):532–538. doi:10.1067/S0190-9622(03)00428-6
Klob: Cited by Horgan E (1930) Hemangioma of Uterus. Surg Gynecol Obstet 50:990
Hensley ML, Maki R, Venkatraman E, Geller G, Lovegren M, Aghajanian C et al (2002) Gemcitabine and docetaxel in patients with unresectable leiomyosarcoma: results of a phase II trial. J Clin Oncol 20(12):2824–2831. doi:10.1200/JCO.2002.11.050
Penel N, Lansiaux A, Adenis A (2007) Angiosarcomas and taxanes. Curr Treat Options Oncol 8:428–434
Nagano T, Yamada Y, Ikeda T, Kanki H, Kamo T, Nishigori C (2007) Docetaxel: a therapeutic option in the treatment of cutaneous angiosarcoma: report of 9 patients. Cancer 110(3):648–651. doi:10.1002/cncr.22822
Tallini G, Price FV, Carcangiu ML (1993) Epithelioid angiosarcoma arising in uterine leiomyomas. Am J Clin Pathol 100(5):514–518
Drachenberg CB, Faust FJ, Borkowski A, Papadimitriou JC (1994) Epithelioid angiosarcoma of the uterus arising in a leiomyoma with associated ovarian and tubal angiomatosis. Am J Clin Pathol 102(3):388–389
Quinonez GE, Paraskevas MP, Diocee MS, Lorimer SM (1991) Angiosarcoma of the uterus: a case report. Am J Obstet Gynecol 164(1 Pt 1):90–92
Ongkasuwan C, Taylor JE, Tang CK, Prempree T (1982) Angiosarcomas of the uterus and ovary: clinicopathologic report. Cancer 49(7):1469–1475. doi:10.1002/1097-0142(19820401)49:7<1469::AID-CNCR2820490726>3.0.CO;2-K
Purola E, Strandell R (1967) Haemangioendothelioma of the uterus. Ann Chir Gynaecol Fenn 56(1):102–104
Ehrmann RL, Griffiths CT (1979) Malignant hemangioendothelioma of the uterus. Gynecol Oncol 8(3):376–383. doi:10.1016/0090-8258(79)90048-9
Stout AP (1943) Hemangio-endothelioma: a tumor of blood vessels featuring vascular endothelial cells. Ann Surg 118(3):445–464. doi:10.1097/00000658-194309000-00014
Kevorkian AY (1940). Hemangioma of the uterus treated with Roentgen rays. N Engl J Med 223(1):1–3
Woll PJ, van Glabbeke M, Hohenberger P, Le Cesne A, Gronchi A, Hoekstra HJ, et al (2007) EORTC soft tissue and bone sarcoma group. Adjuvant chemotherapy (CT) with doxorubicin and ifosfamide in resected soft tissue sarcoma (STS): interim analysis of a randomised phase III trial. J Clin Oncol 25 (2007 ASCO Annual Meeting Proceedings Part I.No. 18S (June 20 Supplement)):10008
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Olawaiye, A.B., Morgan, J.A., Goodman, A. et al. Epithelioid angiosarcoma of the uterus: a review of management. Arch Gynecol Obstet 278, 401–404 (2008). https://doi.org/10.1007/s00404-008-0727-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00404-008-0727-z